中肽生化目录肽版块全新呈现，致力于打造全球最全面的多肽供应平台！我们专业的学术团队将时刻追踪最新最热的研究动向，帮助您发现实际需求，并以最高质量标准提供您所需要的产品。我们将我们将不定期更新产品列表，为您最大限度地节约科研时间，敬请广大客户朋友关注！
CANS-004A
Ile-Met-Gln-Val-Pro-Phe-Ser-Val
Ile-Met-Gln-Val-Pro-Phe-Ser-Val
Ile-Met-Gln-Val-Pro-Phe-Ser-Val
Size：1.0mg
P1(RMB)：215
MW：920.2
One letter sequence：IMQVPFSV
Molecular Formula：C43H69N9O11S1
Description：Peptide that contains modified sequence of the gp 100 epitope gp(209-217), in which a methionine replaced the natural threonine at position 2. This peptide also binds to the HLA-A2 molecule with greater affinity than the unmodified peptide and has exhibited a good ability to stimulate melonomareactive cytotoxic T lymphocytes (CTLs) in vitro when used for sensitization of peripheral blood mononuclear cells. This synthetic peptide holds promise for the development of novel cancer immunotherapies.
Literature Reference：S.A. Rosenberg et al., Nature Med<$>., 4, 321 (1998)
Cas：
P1(RMB)：215
MW：920.2
One letter sequence：IMQVPFSV
Molecular Formula：C43H69N9O11S1
Description：Peptide that contains modified sequence of the gp 100 epitope gp(209-217), in which a methionine replaced the natural threonine at position 2. This peptide also binds to the HLA-A2 molecule with greater affinity than the unmodified peptide and has exhibited a good ability to stimulate melonomareactive cytotoxic T lymphocytes (CTLs) in vitro when used for sensitization of peripheral blood mononuclear cells. This synthetic peptide holds promise for the development of novel cancer immunotherapies.
Literature Reference：S.A. Rosenberg et al., Nature Med<$>., 4, 321 (1998)
Cas：
